College Course Offered on Calling out Scientific Crap
From STAT: Two professors at the University of Washington will be offering a new course, "Calling Bullshit In the Age of Big Data." The class...
Abilify Drives Users to Binge on Risky Behaviors
From Daily Mail: The anti-psychotic drug Abilify is at the center of hundreds of lawsuits accusing the drug of dangerous side effects including compulsive gambling,...
Interpersonal Therapy May Prevent Postpartum Depression
Interpersonal therapy reduces the risk of postpartum depression in mothers on public assistance during first 6 months after giving birth.
Individuals With Low Incomes More Likely to Have Chronic Pain
Findings show that participants with lower levels of education and SES suffer from more chronic pain.
Study Finds No Correlation between Personality at 14 and 77
This result calls into question popular notions about the correlations between personality and later-life achievement and health outcomes.
Patient Race Associated with Varied Psychiatric Treatment Experiences
Findings point to association between race and the mental health care experiences of African-American and White veterans.
FDA Approved Drugs may Become Riskier
From the Center for Health Journalism: President Trump's plans to speed up the process of FDA drug approvals, in combination with the increase of off-label...
You Might be in a Medical Experiment and not Even Know it
From Aeon: Medical experiments are increasingly being conducted without the informed consent of participants.
Article →
How big Pharma’s Lust for Profit Harms Their Customers
From AlterNet: The increasing pace at which the FDA is approving new drugs can lead to significant risks to patient safety. Drugs that once would have...
I do Hate to Tell you This, but…
In this commentary for In the Pipeline, Derek Lowe highlights the results from a recent FDA report showing that the vast majority of all drugs...
Trials Comparing Treatments for Depression Favor Pharmacotherapy when Statisticians Involved
A meta-analysis looks at the effects of researcher background on study findings for trials comparing pharmacotherapy and psychotherapy for depression.
Cancer Drug Offers a Cautionary Tale of Deregulating the FDA
To illustrate the dangers of Trump's plans to deregulate the FDA, Susan Perry from MinnPost provides a cautionary tale about Tarceva, a drug approved by the...
Research Shows Mindfulness can Decrease Anxiety
A new study explores the impact of a Mindfulness-Based intervention on stress-related biomarkers in individuals diagnosed with Generalized Anxiety Disorder (GAD).
The Reasons why Some of us Just Can’t Stop Worrying
From The British Psychological Society: A new review in Biological Psychiatry highlights the cognitive and emotional factors that contribute to prolonged bouts of worry.
Article →
Trump Wants to Blow up the FDA
From STAT: President Trump plans to decrease regulations on the Food and Drug Administration. Medical experts and healthcare professionals have expressed concerns that this could expose...
New Medications Fail to Show Efficacy for Alzheimer’s Disease
Three phase III clinical trials assessing the efficacy of Lundbeck’s investigational drug idalopirdine for Alzheimer’s disease have failed
Alternative Therapies for Adolescent Depression as Effective as CBT, Study Finds
Brief psychodynamic and psychosocial interventions help maintain reduced depressive symptoms
Youngest Children in Class More Likely to get ‘ADHD’ Drugs
The researchers suggest that developmental immaturity is mislabelled as a mental disorder and unnecessarily treated with stimulant medication
Quitting Smoking May Help with Depression
A new study suggests that smoking cessation is related to depressive symptom improvement, but that depression may also make it harder to quit.
New Data Supports Acupuncture as a Treatment for Depression
Researchers found acupuncture effective in the treatment of chronic pain and depression
Physicians Underestimate Harms and Overestimate Benefits of Treatment
A new study analyzed over 13,000 doctors and found that physicians had a poor understanding of risks and benefits in every field, including psychopharmaceutical prescription, to CT scans, and cancer screening.
Neuroscience-based Treatment Program Proposed for Adolescent Depression
A study published in Frontiers in Human Neuroscience proposes a new model for the treatment of adolescents diagnosed with major depressive disorder (MDD).
Children with ‘ADHD’ Commonly Prescribed Antipsychotics
Despite little evidence for benefit, and substantial risk of harm, antipsychotics are commonly prescribed to children diagnosed with ADHD
Researcher Acknowledges His Mistakes in Understanding Schizophrenia
Sir Robin Murray, a professor at the Institute of Psychiatry, Psychology, and Neuroscience in London, states that he ignored social factors that contribute to ‘schizophrenia’ for too long. He also reports that he neglected the negative effects antipsychotic medication has on the brain.
Many Patient Advocacy Organizations Are Funded By Industry
New research investigates the financial conflicts of interest (FCOI) of patient advocacy organizations (PAOs) in the United States.